[ET Net News Agency, 17 September 2021] SIMCERE PHARMA (02096) fell 1.26% to HK$7.08.
It hits an intra-day low of HK$7.03, hitting a historical low, and an intra-day high of
HK$7.43. The total shares traded was 101,000, with a value of HK$718,230. The active
buy/sell ratio is 52:48, with net buying turnover of HK$25,580. MERRILL LYNCH FE accounts
for greatest net responsive buying turnover of HK$80,950, with volume weighted average
price of HK$7.143. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling
turnover of HK$65,653, with volume weighted average price of HK$7.034. The stock has
fallen a combined 10.38% over the past 5 consecutive trading days.
The Hang Seng Index now fell 149 points, or 0.61% to 24,518; the Hang Seng China
Enterprises Index now fell 29 points, or 0.34% to 8,776; the Hang Seng TECH Index now rose
26 points, or 0.42% to 6,259; with an overall turnover of HK$13.86b.
The SSE Composite Index now rose 5 points, or 0.14% to 3,612, with an overall turnover
of RMB59.4b.
The SZSE Component Index now rose 23 points, or 0.16% to 14,281, with an overall
turnover of RMB29.99b.
Basic Information
-------------------------------------------
Nominal 7.080 % Chg -1.26%
High 7.430 Low 7.030
Shares Tr 101,000 Turnover 718,230
10-D SMA 7.636 %H.V 39.738
20-D SMA 7.682 VWAP 7.111
50-D SMA 9.063 RSI14 31.000
-------------------------------------------
Status: Hitting a historical low, active buy/sell ratio is 52:48, with net buying
turnover of HK$25,580, falling a combined 10.38% over the past 5 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SIMCERE PHARMA (02096) 7.08 -1.26
SIHUAN PHARM (00460) 2.00 +0.50
CMS (00867) 14.52 +0.41
LEE'S PHARM (00950) 4.01 Unchanged
CSPC PHARMA (01093) 9.26 +0.87
SINO BIOPHARM (01177) 6.29 +0.32
FOSUN PHARMA (02196) 44.55 +0.11
WUXI APPTEC (02359) 170.60 +0.35
HANSOH PHARMA (03692) 19.66 +1.87
PHARMARON (03759) 177.40 -0.11
-------------------------------------------------
(ed)